RadPharm Announces Hiring of Industry Veteran to Role of
Vice President, Sales and Marketing
Kevin Duffy Tapped to Lead Global Business Development Efforts
Princeton, NJ – September 17, 2008. RadPharm Inc, a leading provider of centralized imaging review services to the global bio-pharmaceutical industry, announced today that Kevin D. Duffy has joined the Company as Vice President, Sales and Marketing, Global Business Development. In this role, Kevin will direct the strategic oversight of the global sales process and coordinate all corporate marketing initiatives.
“Kevin is an excellent addition to the RadPharm team,” said Ronald A. Berg, CEO, RadPharm. “He is an accomplished professional and sales veteran and I am certain his proven skills and strong customer focus will enable him to play a significant role in expanding our global market position.”
Mr. Duffy brings to RadPharm over 25 years of experience in the healthcare industry. Prior to joining RadPharm, Mr. Duffy served as Executive Vice President, Global Business Development for Patheon, Inc and Chief Relationship Officer at Omnicare Clinical Research. His responsibility has spanned global sales team management, corporate marketing, global proposal development and quotations, and client contracts and training.
He holds a Masters of Business Administration degree from Pepperdine University and a Bachelor of Arts degree in Economics from the University of Michigan.
About RadPharm Inc.
RadPharm, a leading imaging core lab, provides complete image management services to global pharmaceutical, biotechnology and medical device organizations, facilitating successful new drug development. RadPharm employs full-time, board certified, sub-specialty trained radiologists, nuclear physicians and medical oncologists to focus on the Medicine Behind the Image™ and offer global trial sponsors medical expertise, advanced technology and proven operational processes to deliver accurate, timely trial data. RadPharm has supported over 300 clinical trials across more than 60 countries and 5000 unique sites.
|